Naproxen Versus Tramadol for Post Cesarean Pain Control

NCT ID: NCT01165814

Last Updated: 2010-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-08-31

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Oral naproxen might be more efficacious for post-cesarean pain-control and have better side-effects profile than oral tramadol.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tramadol at fixed intervals

Group Type ACTIVE_COMPARATOR

Naproxen Tramadol

Intervention Type DRUG

Tramadol on request

Group Type ACTIVE_COMPARATOR

Naproxen Tramadol

Intervention Type DRUG

Naproxen at fixed intervals

Group Type ACTIVE_COMPARATOR

Naproxen Tramadol

Intervention Type DRUG

Naproxen on request

Group Type ACTIVE_COMPARATOR

Naproxen Tramadol

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naproxen Tramadol

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients after cesarean section

Exclusion Criteria

* emergent CS
* hypersensitivity to drug
* drug abuse
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bnai Zion Medical Center

OTHER_GOV

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bnai Zion Medical Center

Haifa, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRAMNAP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management Of Pain After Cesarean Trial
NCT03929640 TERMINATED PHASE3
Naproxen Codeine in Arthroscopic Surgery
NCT01952652 COMPLETED PHASE4
Towards Enhanced Recovery After Cesarean
NCT04612920 COMPLETED EARLY_PHASE1